Emboline

Santa Cruz, United States Founded: 2011 • Age: 15 yrs
Aortic embolic protection devices are developed for cardiovascular procedures.
Request Access

About Emboline

Emboline is a company based in Santa Cruz (United States) founded in 2011.. Emboline has raised $81.92 million across 4 funding rounds from investors including GAM Investments, ShangBay Capital and SV Tech Ventures. The company has 16 employees as of December 31, 2024. Emboline offers products and services including Emboliner Catheter. Emboline operates in a competitive market with competitors including Claret Medical, Protembis, Synaptive Medical, Filterlex Medical and Keystone Heart, among others.

  • Headquarter Santa Cruz, United States
  • Employees 16 as on 31 Dec, 2024
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Emboline Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $81.92 M (USD)

    in 4 rounds

  • Latest Funding Round
    $55.36 M (USD), Series D

    May 21, 2021

  • Investors
  • Employee Count
    16

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Emboline

Emboline offers a comprehensive portfolio of products and services, including Emboliner Catheter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Catheter that captures emboli during TAVR to prevent brain lesions

People of Emboline
Headcount 1-10
Employee Profiles 8
Employee Profiles
People
Laura A. Brenton
Sr. Vice President, Clinical & Medical Affairs
People
Duda Markovic
Director Clinical Affairs at Emboline
People
Mark Caires
Chief Financial Officer
People
Eric Storne
Vice President Of Marketing And Clinical Relations

Unlock access to complete

Funding Insights of Emboline

Emboline has successfully raised a total of $81.92M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $55.36 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series D — $55.4M
  • First Round

    (19 Apr 2018)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2021 Amount Series D - Emboline Valuation Matrix Capital Management
Jan, 2021 Amount Series C - Emboline Valuation

investors

Jan, 2020 Amount Series B - Emboline Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Emboline

Emboline has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include GAM Investments, ShangBay Capital and SV Tech Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Life sciences and tech focused VC firm funding companies in the US and Israel
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Emboline

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Emboline

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Emboline Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Emboline

Emboline operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Claret Medical, Protembis, Synaptive Medical, Filterlex Medical and Keystone Heart, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Cerebral vascular protection systems for endovascular procedures are developed.
domain founded_year HQ Location
Manufacturer of cerebral protection device
domain founded_year HQ Location
Planning and imaging solutions for neurosurgery are developed.
domain founded_year HQ Location
Developer of an embolic protection device
domain founded_year HQ Location
Embolic cerebral protection devices
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Emboline

Frequently Asked Questions about Emboline

When was Emboline founded?

Emboline was founded in 2011 and raised its 1st funding round 7 years after it was founded.

Where is Emboline located?

Emboline is headquartered in Santa Cruz, United States. It is registered at Santa Cruz, California, United States.

Is Emboline a funded company?

Emboline is a funded company, having raised a total of $81.92M across 4 funding rounds to date. The company's 1st funding round was a Series B of $5M, raised on Apr 19, 2018.

How many employees does Emboline have?

As of Dec 31, 2024, the latest employee count at Emboline is 16.

What does Emboline do?

Emboline was founded in 2011 in Santa Cruz, United States, within the medical device sector. An aortic embolic protection device known as the Emboliner is developed to prevent embolic events, such as strokes, during catheter-based heart valve replacements. The device features a mesh filter deployed in the aorta, allowing procedures to proceed under protection. Operations focus on interventional cardiology applications across the United States.

Who are the top competitors of Emboline?

Emboline's top competitors include Protembis, Synaptive Medical and Claret Medical.

What products or services does Emboline offer?

Emboline offers Emboliner Catheter.

Who are Emboline's investors?

Emboline has 4 investors. Key investors include GAM Investments, ShangBay Capital, SV Tech Ventures, and Matrix Capital Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available